Our in vivo experiments further confirmed that autophagy was activated in OVA-induced asthma models, and the application of autophagy inhibitor CQ significantly reversed Th2 cytokines release (IL-5/IL-13), airway resistance and remodeling. This evidence concerns the gene IL13 and asthma.